Abstract: A computer-implemented automated monitoring and behavioral health treatment recommendation method comprising: receiving a set of data from a patient sensor and a set of data from a caregiver for a patient; computing, via a processor, an behavioral health dosage for the patient; correlating, via a processor, the behavioral health dosage to a corpus of behavioral health dosage treatment data; and calibrating the behavioral health dosage, via processor; in light of a cohort of similar patient behavioral health dosages and; measuring a progress metric towards a set treatment goal of the patient, via the processor.

Abstract: Provided here are antibodies that bind Protein S, and methods of making and using such antibodies. In some embodiments, the Protein S antibodies provided herein are useful for treating a bleeding disorder or platelet disorder, or a condition characterized by reduced or impaired blood coagulation and/or clotting.

Abstract: Described herein are systems, devices, and methods for removing material from patient vasculature. In some embodiments, an aspiration device may include a sheath and a catheter slidably disposed within the sheath and defining a lumen. The catheter may include a distal end portion and an elongate portion, the distal end portion being disposable adjacent to a clot, the elongate portion being couplable to a vacuum source that is configured to apply a negative pressure to the lumen to draw the clot into the distal end portion. The distal end portion may include a plurality of sections, each of the plurality of sections having a different cut pattern.

Abstract: A method includes obtaining a rule that is associated with a segment of a map, determining a state for use in evaluation of the rule, evaluating the rule using the state, identifying an action to be performed based on a result of evaluating the rule using the state, and utilizing the action to be performed as an input to an automated control system of a vehicle.

Abstract: Provided herein are antibodies that bind signal regulatory protein gamma (SIRPy), as well as SIRP? and/or SIRP?1, and methods of using such antibodies (referred to as SIRP antibodies). In some embodiments, the SIRP antibodies are human monoclonal antibodies that bind human SIRPy as well as SIRP? and/or SIRP?1. In some embodiments, the SIRP antibodies provided herein are useful for treating a disease or condition associated with overactivation and/or hyperproliferation of lymphocytes, myeloid cells, or a combination thereof, or a disease or condition associated with SIRP?, SIRP?1 and/or SIRPy activity.

Abstract: A kit of eyewear that comprises a plurality of eyewear elements, each having a frame and a lens associated with each eye. Each of the eyewear elements have an occluded portion of at least one lens; at least some of the eyewear elements having different occlusion areas on the left and right lenses; and the eyewear elements having different occlusions patterns from each other.

Abstract: Provided herein are antibodies that bind signal regulatory protein SIRPa, SIRPß1, or a combination of SIRPa and SIRP?1, and methods of using such antibodies. In some embodiments, the antibodies are human monoclonal antibodies that bind human SIRPa and/or SIRP?1. In some embodiments, the antibodies provided herein are useful for treating a disease or condition associated with overactivation and/or hyperproliferation of myeloid cells, or a disease or condition associated with SIRPa and/or SIRP?1 activity.

Abstract: Provided here are antibodies that bind Protein S, and methods of making and using such antibodies. In some embodiments, the Protein S antibodies provided herein are useful for treating a bleeding disorder or platelet disorder, or a condition characterized by reduced or impaired blood coagulation and/or clotting, e.g. by depleting the circulating levels of TFPI, by disrupting a Protein S-TFPI complex, and/or by preventing the formation of a Protein S-TFPI complex.

Abstract: Provided here are antibodies that bind Protein S, and methods of making and using such antibodies. In some embodiments, the Protein S antibodies provided herein are useful for treating a bleeding disorder or platelet disorder, or a condition characterized by reduced or impaired blood coagulation and/or clotting.

Abstract: Embodiments of the present disclosure generally relate to methods for analyzing the effectiveness of preventative measures on the spread of illnesses, such as COVID-19, on living organisms. More particularly, embodiments of the present disclosure relate to methods for identifying the effectiveness of preventative measures, processes, equipment and other available data, and providing indicators and methods of visualization the effectiveness of preventative measures on the spread of an illness.

Abstract: Embodiments of the present disclosure generally relate to methods for analyzing survivability of illnesses, such as COVID-19. More particularly, embodiments of the present disclosure relate to methods for identifying correlations and influencing factors between genetic markers, lifestyle, and other available data that lead to predictions of the effectiveness of medical treatments, predicting results of mass exposure to an illness based on a population's genomes and other available data, and providing indicators and methods of visualization for survivability of a viral infection or cancer in any living organism.

Abstract: Embodiments of the present disclosure generally relate to methods for analyzing survivability of illnesses, such as COVID-19. More particularly, embodiments of the present disclosure relate to methods for identifying correlations and influencing factors between genetic markers, lifestyle, and other available data that lead to predictions of the effectiveness of medical treatments, predicting results of mass exposure to an illness based on a population's genomes and other available data, and providing indicators and methods of visualization for survivability of a viral infection or cancer in any living organism.

Abstract: Embodiments of the present disclosure generally relate to methods for analyzing outcomes of illnesses, such as COVID-19, on living organisms. More particularly, embodiments of the present disclosure relate to methods for identifying risk of illness based on genetic markers and other available data, predicting results of mass exposure to an Illness based on a populations genomes and other available data, and providing indicators and methods of visualization for probability of illness in any living organism.

Abstract: Embodiments of the present disclosure generally relate to methods for analyzing outcomes of illnesses, such as COVID-19, on living organisms. More particularly, embodiments of the present disclosure relate to methods for identifying risk of illness based on genetic markers and other available data, predicting results of mass exposure to an Illness based on a populations genomes and other available data, and providing indicators and methods of visualization for probability of illness in any living organism.

Abstract: A method is provided for void-free Ru metal filling of features in a substrate. The method includes providing a substrate containing features, depositing a Ru metal layer in the features, removing the Ru metal layer from a field area around an opening of the features, and depositing additional Ru metal in the features, where the additional Ru metal is deposited in the features at a higher rate than on the field area. According to one embodiment, the additional Ru metal is deposited until the features are fully filled with Ru metal.

Abstract: During the process of compressing air, atmospheric air along with water vapor and airborne contaminants are ingested into the air compressor. Many of these compressors utilize oil for lubrication, sealing and cooling. A compressor system utilizes drain valves to remove the condensate that accumulates in the system which are typically located on the compressor, moisture separators, coalescing filters, receivers, dryers, and drip legs. While the drain valves successfully remove the condensate, this condensate is now contaminated with lubricant. The compressor system also includes a filter for the removal of lubricant from the condensed water so that the water can be discharged to sewer. The filter is arranged to house a series of vertically stacked filter cartridges, each cartridge structured to pass fluid flow to the other cartridge. The housing and the cartridges each having registration surfaces to position the filter within the housing and discourage removal of the same.

Abstract: During the process of compressing air, atmospheric air along with water vapor and airborne contaminants are ingested into the air compressor. Many of these compressors utilize oil for lubrication, sealing and cooling. A compressor system utilizes drain valves to remove the condensate that accumulates in the system which are typically located on the compressor, moisture separators, coalescing filters, receivers, dryers, and drip legs. While the drain valves successfully remove the condensate, this condensate is now contaminated with lubricant. The compressor system also includes a filter for the removal of lubricant from the condensed water so that the water can be discharged to sewer. The filter is arranged to house a series of vertically stacked filter cartridges, each cartridge structured to pass fluid flow to the other cartridge. The housing is connected to the filter cartridges via a variable length pipe extension dependent on the number of filter cartridges used in an application.

Abstract: A method is provided for void-free Ru metal filling of features in a substrate. The method includes providing a substrate containing features, depositing a Ru metal layer in the features, removing the Ru metal layer from a field area around an opening of the features, and depositing additional Ru metal in the features, where the additional Ru metal is deposited in the features at a higher rate than on the field area. According to one embodiment, the additional Ru metal is deposited until the features are fully filled with Ru metal.

Abstract: During the process of compressing air, atmospheric air along with water vapor and airborne contaminants are ingested into the air compressor. Many of these compressors utilize oil for lubrication, sealing and cooling. A compressor system utilizes drain valves to remove the condensate that accumulates in the system which are typically located on the compressor, moisture separators, coalescing filters, receivers, dryers, and drip legs. While the drain valves successfully remove the condensate, this condensate is now contaminated with lubricant. The compressor system also includes a filter for the removal of lubricant from the condensed water so that the water can be discharged to sewer. The filter is arranged to house a series of vertically stacked filter cartridges, each cartridge structured to pass fluid flow to the other cartridge. The housing includes a series of outlets having removable covers that, when removed, permit discharge of filtered water.

Abstract: During the process of compressing air, atmospheric air along with water vapor and airborne contaminants are ingested into the air compressor. Many of these compressors utilize oil for lubrication, sealing and cooling. A compressor system utilizes drain valves to remove the condensate that accumulates in the system which are typically located on the compressor, moisture separators, coalescing filters, receivers, dryers, and drip legs. While the drain valves successfully remove the condensate, this condensate is now contaminated with lubricant. The compressor system also includes a filter for the removal of lubricant from the condensed water so that the water can be discharged to sewer. The filter is arranged to house a series of vertically stacked filter cartridges, each cartridge structured to pass fluid flow to the other cartridge. The housing and the cartridges each having registration surfaces to position the filter within the housing and discourage removal of the same.